Travere Therapeutics, Inc.TVTXNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+19.5%
5Y CAGR+19.9%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+19.5%/yr
vs +17.5%/yr prior
5Y CAGR
+19.9%/yr
Consistent
Acceleration
+2.0pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.5x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $337.20M | +27.7% |
| 2024 | $264.12M | -0.5% |
| 2023 | $265.54M | +34.4% |
| 2022 | $197.52M | +56.4% |
| 2021 | $126.28M | -7.0% |
| 2020 | $135.80M | +5.3% |
| 2019 | $128.95M | +24.4% |
| 2018 | $103.65M | -0.3% |
| 2017 | $103.96M | +6.1% |
| 2016 | $98.02M | - |